Pharmafile Logo

Peter Impey

Getting real about patient support

The right application of data can have a transformative effect on patient care

- PMLiVE

Get Real! The Rise of Observational Data In Healthcare

Real world data is now becoming a serious research tool for pharma, but just what can it add to the golden standard that is the randomised clinical trial?

- PMLiVE

Pfizer launches lupus study with 23andMe

Aims to enroll 5,000 patients into new geneticresearch study

- PMLiVE

Can Advertising adds new lead designer

CorinneJones brings experience from DDB Remedy and Havas Life Medicom

UK flag

London life science growth boosted by Takeda

Japanese firm adds to recent surge in pharma spending in the capital

- PMLiVE

FDA warns of safety concern with SGLT2 inhibitors

Some drugs have been linked to high levels of blood acids

- PMLiVE

Allergy specialist Circassia buys asthma firms

British-based company acquires Sweden’s Aerocrine and privately held Prosonix

- PMLiVE

Flurry of FDA guidance firms up biosimilar policy

The American regulator has released new biosimilar Q&A document

EU flag

Europe wants scientific advice to become pluralistic

Commission endeavours to create a new science committee and reject a single advisor model

- PMLiVE

Takeda strengthens leadership team with business unit director

Craig Adkins takes up the position after being at the firm for ten years

Teva Pharma logo

Teva says chronic migraine drug is ready for phase III

TEV-48125 efficacy “has not previously been achieved”

Can Cinderella save us?

Pharma should pay into antibiotic resistance fund

Claims stem from the latest UK Review on Antimicrobial Resistance

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links